Clinical Trials
3 trialsNCT01782339 2024-06-14
GAMMA
Barts & The London NHS Trust
Phase 2 Completed
NCT00079482 2016-07-21
Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00497315 2009-04-10
PACCORA
University Hospital, Antwerp
Phase 2 Completed